-
Mashup Score: 8Now That We Don't Talk: Should Cancer Centers Bill for Patient Portal Messages in Oncology? - 27 day(s) ago
Published online: March 21, 2024 Request permissions for this article. Massachusetts General Hospital, Concord, MA Now That We Don’t Talk: Should Cancer Centers Bill for Patient Portal Messages in Oncology?. JCO Oncol Pract 0, OP.24.00176 DOI: 10.1200/OP.24.00176 If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download. For more information or tips please see
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Medicaid Privatization: Has the Invisible Hand Led Us Astray? - 2 month(s) ago
Medicaid Privatization: Has the Invisible Hand Led Us Astray? presents timely questions regarding our nation’s healthcare safety-net: (1) What are the consequences when states outsource the administration of Medicaid to private organizations with a profit motive?; (2) Can returning administrative responsibility back to state governments restore any losses to quality and equity experienced by previously privatized public programs?; and (3) Is it time to abandon Medicaid managed care altogether for state-operated fee-for-service or other alternative administrative arrangements?
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet-
"Medicaid Privatization: Has the Invisible Hand Led Us Astray?" New #JCOOP Editorial by @lsaulsbe: Is it time to abandon Medicaid-managed care altogether for state-operated fee-for-service or other alternative administrative arrangements? ➡️ https://t.co/5TifCRcslo
-
-
Mashup Score: 2Medicaid Privatization: Has the Invisible Hand Led Us Astray? - 2 month(s) ago
Medicaid Privatization: Has the Invisible Hand Led Us Astray? presents timely questions regarding our nation’s healthcare safety-net: (1) What are the consequences when states outsource the administration of Medicaid to private organizations with a profit motive?; (2) Can returning administrative responsibility back to state governments restore any losses to quality and equity experienced by previously privatized public programs?; and (3) Is it time to abandon Medicaid managed care altogether for state-operated fee-for-service or other alternative administrative arrangements?
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet-
"Medicaid Privatization: Has the Invisible Hand Led Us Astray?" New #JCOOP Editorial by @lsaulsbe: Is it time to abandon Medicaid-managed care altogether for state-operated fee-for-service or other alternative administrative arrangements? ➡️ https://t.co/5TifCRcslo
-
-
Mashup Score: 5Vitamin and Mineral Supplementation, Weight Gain, and Poor Appetite in Patients With Cancer: Many Questions and Fewer Answers - 3 month(s) ago
Patients with cancer or with a history of cancer often seek nutritional advice. In turn, cancer health care providers are often asked questions related to nutrition and cancer. Should I take high-dose vitamins or other high-dose supplements? Should I take a regular-dose vitamin or other regular-dose nutritional supplements? Will I experience weight loss during postoperative chemotherapy? What should be my weight goals during and after adjuvant therapy? In the setting of advanced cancer, what should I do to keep my appetite and weight up? This review attempts to provide data-driven answers to some of these commonly posed questions.
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet-
🥗 This #JCOOP review attempts to provide data-driven answers to commonly posed questions about nutrition and cancer including: high-dose vs regular-dose vitamins and supplements, specialized diets, appetite, and weight. https://t.co/Psk6wdYeuD
-
-
Mashup Score: 0Case-Based Clinical Guidance on Dosing and Management of the Hepatic Artery Infusion Chemotherapy Pump - 6 month(s) ago
Hepatic artery infusion (HAI) delivers localized high-dose floxuridine directly to liver tumors through an implanted pump. While patients are undergoing active treatment, the pump is refilled with chemotherapy alternating with saline every 2 weeks using a specialized noncoring needle. Numerous clinical scenarios influence the dosing of floxuridine, which do not conform to the usual dose modification schema for systemic chemotherapy. This article aims to provide practical clinical management solutions to overcome the common challenges faced by oncologists in the real-world management of HAI pump therapy.
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet-
#JCOOP Review by @AndreaCercek et al.: This article aims to provide practical clinical management solutions to overcome the common challenges faced by oncologists in the real-world management of hepatic artery infusion pump therapy. ➡️ https://t.co/WolNCTJ0fD https://t.co/y43PVErcWw
-
-
Mashup Score: 0Systemic Therapy for Tumor Control in Well-Differentiated Metastatic Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline Q and A - 7 month(s) ago
ASCO recently published new guidance on systemic therapy for tumor control in well-differentiated metastatic gastrointestinal and pancreatic neuroendocrine tumors in the Journal of Clinical Oncology. A companion Q and A article in the JCO-OP addresses some of the questions that clinicians may face as they implement these recommendations into clinical practice, including the role of somatostatin receptors and observation, definition of terms used within the guideline, considerations related to therapy options for G3 NETs, and future direction in research and treatment. ASCO also plans to address recommendations on the topic of symptom control of GEP-NETs in a forthcoming guideline
Source: ascopubs.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
❓ #JCOOP Q&A for @ASCO's new guideline for systemic therapy for tumor control in well-differentiated metastatic gastrointestinal and pancreatic #neuroendocrine tumors. ➡️ https://t.co/upC2tLmwQ6 #NET #pancsm @JaydiDelRivero
-
-
Mashup Score: 1
Over the past decade, tremendous efforts have been made in the development of targeted agents in non–small-cell lung cancer (NSCLC) with nonsquamous histology. Pivotal studies have used next-generation sequencing to select the patient population harboring oncogenic driver alterations that are targetable with targeted therapies. As treatment paradigm rapidly evolves for patients with rare oncogene-driven NSCLC, updated comprehensive overview of diagnostic approach and treatment options is paramount in clinical settings. In this review article, we discuss the epidemiology, molecular testing, and landmark clinical trials addressing the targeted agents for ROS1 rearrangement, METex14 skipping mutation, EGFR exon 20 insertion, KRAS G12C mutation, HER2 mutation, RET fusion, NTRK fusion, and BRAF mutations.
Source: ascopubs.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🔬Over the past decade, tremendous efforts have been made in the development of targeted agents in nonsquamous #NSCLC #lungcancer. This #JCOOP review discusses the epidemiology, testing, & landmark clinical trials for ROS1, EGFR, KRAS, BRAF etc ➡️ https://t.co/qfi4LIDGWx #lcsm https://t.co/gOiqznNu2T
-
-
Mashup Score: 0Lessons Learned and Practice Pearls: Optimal Integration of Electronic Patient-Reported Outcomes in the Medical Oncology Clinic - 7 month(s) ago
This editorial reviews the many opportunities and obstacles associated with ePRO integration in oncology
Source: ascopubs.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#JCOOP Editorial: Guidelines for #ePRO selection, implementation, & evaluation need to be widely disseminated. As ePROs are more commonly used, thoughtful discussions regarding implementation & appropriate use of the data generated is essential ➡️ https://t.co/dB3HpCbULC https://t.co/NuKwdkwfVa
-
-
Mashup Score: 1Clicking Away to Capture Cancer Staging—The Benefits and Challenges of Completing Standardized Staging Modules - 7 month(s) ago
This article by Neelima Vidula and Jeffrey Peppercorn @MGHCancerCenter explores the benefits and challenges of completing standardized modules for cancer staging, and opportunities to improve module compliance while reducing burnout
Source: ascopubs.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#JCOOP Editorial Drs. Vidula & @EthicsdoctorP: "By partnering with innovative tech & clinicians, the benefits of staging modules for care delivery, QI, billing, & research can be realized while optimizing the efforts of clinicians toward direct pt care." https://t.co/Um0NiuDkMh
-
-
Mashup Score: 1Testicular Cancer: The Test is to Focus on Important Research - 7 month(s) ago
AUTHOR’S DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationship s may not relate to the subject matter of this manuscript. For more information about ASCO’s conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/op/authors/author
Source: ascopubs.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#JCOOP Editorial: New research for #TesticularCancer should focus on 1) improving cure rates for bad-risk #NSGCT 2) better management of late relapse & transformed teratomas 3) identifying new molecular markers to improve dx & prognostication: https://t.co/JYfLLEyYkU
-
#JCOOP Editorial: "Should Cancer Centers Bill for Patient Portal Messages in Oncology?" ⌨️ On optimizing portal message management & promoting further research on best practices, potential disparities & the impact of billing by @EthicsdoctorP. ➡️ https://t.co/sP9p0fN4Fq https://t.co/qHvHEkn2QO